A proficiency testing panel for detecting antibodies against Brucella abortus was developed and evaluated by both primary binding and conventional serological tests, using the guidelines of the World Organisation for Animal Health and the International Organization for Standardization Guide 43-1. All serological tests were judged satisfactory. Among the primary binding tests, the competitive enzyme-linked immunosorbent assay (ELISA 2) and the indirect enzyme-linked immunosorbent assay (ELISA 1), with standard deviation indices (z-scores) of -0.06 and 0.10, respectively, performed best. Similarly, E n numbers (i.e. a way of comparing different measurements of performance) of 0 for both the competitive ELISA 2 and the indirect ELISA 1 indicated that these tests performed best in the initial round of proficiency testing. The conventional serological tests all passed the panel. Comparing data from both the quantitative and qualitative tests demonstrated that this proficiency testing scheme was fit for the purpose for which it was designed.
Introduction
One of the stated purposes of proficiency testing is the overall improvement of laboratory diagnostic performance, thus providing the analyst, the laboratory and the client with the confidence that the results produced by the laboratory are indeed valid.
The challenge was to develop a proficiency panel suitable for use with the wide variety of serological tests available for the detection of antibody to Brucella abortus. These tests have a broad range of performance characteristics (i.e. sensitivity and specificity), as shown by Gall and Nielsen (14) .
A proficiency panel fit for the purpose would require welldefined sera as described by the World Organisation for Animal Health (OIE) (33) . The detection limits and detection of the four major bovine isotypes vary between these different serological tests (22, 24) . As a result, it was essential to ensure that positive sera included in this panel would react unequivocally.
Additionally, other requirements outlined by the OIE (33) were considered, including:
-that the sera were derived from single animals or a pool of animal sera -that these sera were undiluted or diluted in negative sera -that the sera were not lipaemic, haemolysed or contaminated -that these sera were free of infectious agents.
Some of these factors could interfere with the subjective reading and interpretation of conventional serological tests, such as the:
-buffered antigen plate agglutination test (BPAT) -card test (CT) -complement fixation test (CFT) -tube agglutination test (TAT).
Another consideration was the evaluation of results, as outlined by the International Organization for Standardization (ISO) Guide 43-1 (16) , for both quantitative and qualitative tests. The choice of statistics for quantitative tests, including the competitive enzymelinked immunosorbent assay (c-ELISA), the fluorescence polarisation assay (FPA) and the indirect ELISA (iELISA), was described in the ISO Guide 43-1 (16) and ISO 13528 (17) . As a result of the descriptive nature of qualitative data (i.e. positive, negative or suspicious), the choice of statistics was limited.
With the above criteria for guidance, a proficiency panel, which included replicate samples, was developed to analyse repeatability within the laboratory and reproducibility between laboratories. This panel was also intended to provide performance indicators (i.e. z-scores, E n numbers), to aid laboratories and analysts to assess their ability to perform tests competently (18) , and to determine the degree of equivalence (19) between tests, analysts and laboratories.
Materials and methods

Participating laboratories
Three laboratories, all experienced and knowledgeable in laboratory diagnosis of Brucella, participated in the design, preparation and preliminary data evaluation of the proficiency panel. For the purposes of confidentiality, the results of c-ELISA, FPA and iELISA testing were not identified with any particular laboratory.
Sera
Three defined groups of sera (n = 107) were initially assembled and referred to as:
-negative sera -sera from animals from which B. abortus was isolated -serologically positive sera.
The negative sera were from individual Canadian cows that tested negative for the presence of antibodies against B. abortus in all serological tests. Canada has been officially free of bovine brucellosis since 1984. The sera from culture-positive animals were from a pre-1984 serum bank of samples from individual cattle which had been naturally infected with B. abortus. The serologically positive sera were two CFT reactors from Argentina, containing greater than 288 and 1,323 CFT international units per millilitre of serum, respectively, and from which B. abortus had been isolated.
Serological tests
All sera were pre-screened at the Canadian Food Inspection Agency Ottawa Laboratory Fallowfield, to determine the suitability of each serum for proficiency panel inclusion, using the:
The above six tests were performed according to their respective standard operating procedures (SOP): BR-LD011 (7), BR-LD022 (8), BR-PR005 (6), BR-LD014 (5), BR-PR041 (10) and BR-PR040 (9) . The diagnoses were Rev. sci. tech. Off. int. Epiz., 27 (3) made according to the acceptance/rejection criteria approved in their respective SOP.
As described in the SOP, the BPAT and the TAT were performed according to the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (34) .
The CFT SOP was adapted from procedures originally described by Samagh and Boulanger (28) and Alton et al. (2, 3) .
Similarly, the c-ELISA, iELISA and FPA were performed as previously described by Nielsen et al. (23, 25, 26) .
Panel design and preparation
After the initial pre-screening, the number of sera judged suitable for inclusion in the panel was reduced from 107 to 19. Further testing and evaluation resulted in the selection of 15 sera. These 15 sera consisted of nine positive sera and six negative sera. Each serum was aliquoted (0.6 ml) in triplicate (n = 45) into a 96-well plate and lyophilised, after being coded and randomised (1) for placement. These 45 coded sera, identified as an exploratory panel (ID 060116), were shipped to collaborating laboratories in Argentina and Mexico for evaluation by CT, the 2-mercaptoethanol agglutination test (2-ME), the rivanol agglutination test (RIV), c-ELISA and FPA.
In Argentina, the BPA and 2-ME were performed according to standard procedures (29) , and the antigens used were prepared by Senasa, while the c-ELISA and FPA were performed as described by Nielsen et al. (23, 24) .
The CT antigen in Mexico, prepared by Productora Nacional de Biológicos Veterinarios (PRONABIVE), was Rose-Bengal stained, buffered at a pH of 3.65 ± 0.05 and adjusted to 3% cell concentration.
For the RIV test, the method described by Morilla and Bautista (20) was employed. The antigen and the rivanol reagent were provided by PRONABIVE and the serum dilutions used were 1:25, 1:50, 1:100 and 1:200.
After the results from Panel ID 060117 were collated and evaluated, the number of sera for inclusion in the final version of the proficiency panel was further reduced from 15 to 12. The 12 sera consisted of six positive sera and six negative sera. Two of the positive sera were from Argentina while the remainder were sera from the pre-1984 serum bank. All the negative sera were derived from individual Canadian cows.
A second evaluation panel (ID 060403) was prepared and evaluated by the participating laboratories.
Data expression and evaluation
Only the data from the final version of the panel design (Panel ID 060403) were considered for data analysis.
The determination of an assigned value and its uncertainty were the consensus values from the test results as defined by Thompson and Wood (32) , ISO Guide 43-1 (16), the Standards Council of Canada (30) , and ISO 13528 (17) .
For the iELISA, optical density (OD) results for each individual test sample were expressed as a percentage of the mean of the positive controls included on each 96-well microplate after a development time of ten minutes. The percentage of positivity (% P) was calculated as follows: % P = (OD of the test sample ÷ mean OD of the positive control) × 100
Similarly, for the c-ELISA, individual test sample OD results were expressed as a percentage of the mean of the buffer controls included on each 96-well microplate after a development time of ten minutes. Percentage of inhibition (% I) was calculated as follows: % I = 100 -(OD of the test sample ÷ mean OD of the buffer control) × 100 For summary statistics (see 'Results' below), the data for each test were analysed for outliers using the individual test mean plus three standard deviations (31) . However, for performance indicators (i.e. z-scores, E n numbers), outliers must be evaluated within the proficiency scheme and should not be removed (16, 30) .
The c-ELISA, FPA and iELISA data were tested for normal distribution using the D'Agostino and Pearson test (Medcalc 2006, version 8.2.10. for Windows, Mariakerke, Belgium). Before using parametric statistics, such as zscores or E n numbers, normality was verified (12, 16, 30) .
The calculation of the standard deviation index (SDI) or zscores (16, 30, 32) reduces the data to the same standardised values, making it possible to compare results of different quantitative tests without referring to the means, standard deviations or different units of measurement (32) . As a measure of relative accuracy, the SDI was calculated as follows:
SDI (z-scores) = (individual test mean -mean of all the data values)/standard deviation of all the data values
Similarly, a measure of relative precision, the co-efficient of variation (% CV) index (CVI) was calculated as follows:
CVI = % CV of the individual test ÷ % CV of all the data values
In a similar way, E n numbers (21, 30, 31) also transform data into standardised values, taking into account the measures of uncertainty for both the test result and the assigned value, thus allowing for the comparison of various tests with different units of measurement, such as the SDI. Thus, E n numbers were calculated as follows:
Where: 
Results
Two of the three c-ELISA results had 100% agreement, whereas the third c-ELISA gave 97.2% agreement (i.e. 35/36 results). All c-ELISA tests used the same cut-off value of 30% inhibition. The one discrepant value was 34% for a negative serum, which was 4% above the cut-off value.
Similarly, two of the three iELISA results, with cut-off values of 53% and 46% positivity, respectively, had 100% agreement. A third iELISA, using recombinant protein A/G, gave 97.2% agreement with a negative cut-off of 20% positivity (27) . The aberrant result was 24% positivity for a negative serum.
There was 100% agreement between the BPAT performed in Canada and that performed in Argentina.
The remaining conventional serological tests (i.e. the CFT, Rose-Bengal test, TAT and RIV) correctly identified all the sera.
No outliers were detected prior to the calculation of the summary statistics (Table I) , based on the mean plus three standard deviations (31) .
A total of nine FPA were performed (Table I) , using different instrumentation and analysts. The FPA 1, 2, 6, 7 and 9, as shown in Table I , were performed on the same type of instrument (Instrument 1) by five different analysts. There was 100% agreement between FPA 1, 2, 6 and 7. For FPA 9, one triplicate value for one positive serum and three negative sera disagreed (Table I) , resulting in an 88.9% agreement.
The data for FPA 3 and 8 gave 100% agreement. Both of these FPA were performed using a different instrument from that in the earlier FPA tests (i.e. Instrument 2) by two different analysts.
Tests FPA 4 and FPA 5 were performed on two different instruments again (Instruments 3 and 4), using the microplate format, by the same analyst. Once more, there was 100% agreement, although the negative sera produced negative data values with FPA 4. However, these negative values did not affect the final outcome, although the summary statistics were affected, as shown in Table I .
Based on a calculated p-value greater than 0.05 (Table II) , the c-ELISA, FPA and iELISA data were confirmed as having a normal distribution (Medcalc, 2006, version 8.2.10.) before determining their performance measures, such as z-scores and E n numbers.
In Figure 1 , the FPA test results are compared with those of the c-ELISA and iELISA, using the SDI or z-scores as a measure of accuracy. An SDI value of 2 indicates that the c-ELISA, FPA or iELISA individual test means are two standard deviations from their respective mean of all the test values for the c-ELISA, FPA or iELISA. On the other hand, SDI values (z-scores) greater than +2 or less than -2 indicate that the individual test means are not in good agreement with the mean of all the values and are questionable. However, SDI values between -2 and +2 are considered satisfactory (12, 16, 30) . Figure 2 compares the c-ELISA, FPA and iELISA values using the co-efficient of variation index (CVI) as a precision index (a relative measure of precision). Using this measure, CVI values of less than two are considered satisfactory. The majority of the tests gave CVI values of less than one.
As with the SDI scores, E n numbers can be used to compare tests that use different methods of data expression. Thus, Figure 3 compares the c-ELISA, FPA and iELISA tests. Values less than or equal to one are considered satisfactory (16) , indicating that, in this exploratory round of proficiency testing, all the tests were acceptable.
There was no significant difference (p = 1.0) between qualitative and quantitative tests, as shown by ANOVA in E n values between -1 and +1 were judged to be satisfactory. Unlike the standard deviation index, the differences between the test means and their respective assigned values were ordered from the lowest value to the highest value, regardless of test method tests and identify various random and systemic sources of variation, as described by Gall and Nielsen (13) and Dimech et al. (11) .
The calculation of SDI values or normal deviates or z-scores is a statistical method of standardising or normalising a test result relative to standard deviation. Since the SDI units are in standard deviations, this standardisation allows comparisons of the relative positions of tests with different measurement units (15, 32) , such as quantitative serological assays (i.e. FPA, c-ELISA and iELISA), by reducing the data to the same value indicators. A positive SDI value indicates that the test mean was larger than the mean of all the values, whereas a negative SDI value indicates that the test mean was less than the mean of all the values. For instance, the SDI for FPA 4 was -1.94 standard deviations below the mean for all the FPA values. The SDI for the c-ELISA 2 was -0.06 standard deviations below the mean of all the c-ELISA values, a score substantially better than that of the FPA 4. From these standard scores, it is clear that the performance of the c-ELISA 2 was better, relative to the mean of the c-ELISA values, than the FPA 4, relative to the mean of all the FPA values (Fig. 1) . Similarly, an SDI of 0.10 standard deviations for iELISA 1 indicated a better performance than that of FPA 4 but slightly lesser than the c-ELISA 2, relative to their respective group means (assigned values).
Relative performance of the quantitative tests, such as the c-ELISA, FPA and iELISA, may also be compared using E n numbers (16, 30) . In a similar way to the SDI, test results are transformed or reduced to the same value, thus making comparisons between the various tests easier. In this study, the assigned value (i.e. the mean of all the FPA tests combined) and its uncertainty (i.e. the standard deviation of all the FPA tests combined) are consensus values derived from the tests of the participating laboratories (16, 30) . All the tests were considered acceptable, since all the E n numbers were less than or equal to one.
It was interesting to observe the tests using E n numbers as opposed to the tests using SDI. In both data evaluations, the c-ELISA 2 and iELISA 1 had the lowest values, while the FPA 4 and FPA 7 were at the extremes of the abscissa (or x co-ordinate), as shown in Figures 1 and 3 . This suggests that both the SDI and E n numbers were similar when identifying the closeness of agreement between the mean value of a test result and the assigned (consensus) value. Tests between lowest values and the extremes were exactly the same, except that their ranking was different. For instance, FPA 8 had a higher E n number than c-ELISA 3, whereas the emphasis for SDI was the opposite for both tests (e.g. for c-ELISA 3, the SDI was higher than the FPA 8). In fact, the data range between the mean of the test and their respective group means (assigned values) aligned perfectly from the lowest value to the highest value with the E n numbers, regardless of the test. However, for the SDI, the same values were similarly aligned but grouped by test type. This suggests that the E n numbers were better suited for ranking tests or laboratories. For instance, the test with the greatest difference between the mean and the assigned value was FPA 4, with an E n number of -0.317, while the test with the least difference was the c-ELISA 2 or iELISA 1, both of which centred on the abscissa. Based on the definitions for repeatability and reproducibility as described by the OIE (33) , and data evaluation according to the ISO Guide 43-1 (16) and ISO 13528 (17) , it was concluded that the proficiency panel described in this article was fit for the purpose for which it was designed and prepared. Resumen Los autores describen la elaboración y evaluación de un cuadro de análisis de la eficacia en la detección de anticuerpos contra Brucella abortus por medio de pruebas serológicas, tanto de unión primaria como convencionales, utilizando las Directrices de la Organización Mundial de Sanidad Animal y la Guía 43-1 de la Organización Internacional de Normalización. Todas las pruebas serológicas fueron juzgadas satisfactorias. De entre las técnicas de unión primaria, las más eficaces resultaron el ensayo inmunoenzimático de competición (ELISA 2) y el ensayo inmunoenzimático indirecto (ELISA 1), con índices de desviación típica (z-scores) de -0,06 y 0,10 respectivamente. Análogamente, el valor E n (esto es, la medida de rendimiento) de 0,0 obtenido con el ELISA 2 (de competición) y el ELISA 1 (indirecto) denota una eficacia óptima de ambas pruebas en la ronda inicial de análisis. Todas las pruebas serológicas convencionales superaron el examen. La comparación de los datos correspondientes a las pruebas cuantitativas y cualitativas demuestra que este sistema de análisis se ajusta a los fines con que fue concebido.
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